Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone

David Price* (Corresponding Author), William Henley, José Eduardo Delfini Cançado, Leonardo M Fabbri, Huib AM Kerstjens, Alberto Papi, Nicolas Roche, Elif Şen, Dave Singh, Claus Vogelmeier, Sara Barille, Elena Nudo, Victoria Carter, Derek Skinner, Rebecca Vella, George Georges

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)
12 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Interclass difference in pneumonia risk in COPD patients initiating fixed dose inhaled treatment containing extrafine particle beclometasone versus fine particle fluticasone'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences